BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 32623633)

  • 1. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
    Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
    Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
    Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
    Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.
    Xie H; Zhao J; Lian N; Lin S; Xie Q; Zhuo H
    Liver Int; 2020 Jun; 40(6):1321-1326. PubMed ID: 32239591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the COVID-19 associated liver injury.
    Wong YJ; Tan M; Zheng Q; Li JW; Kumar R; Fock KM; Teo EK; Ang TL
    Ann Hepatol; 2020; 19(6):627-634. PubMed ID: 32882393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
    Gu X; Li X; An X; Yang S; Wu S; Yang X; Wang H
    J Clin Lab Anal; 2020 Jul; 34(7):e23391. PubMed ID: 32488888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.
    Xin S; Xu J; Yu Y
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):219-226. PubMed ID: 32530989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Abnormal liver function tests.
    Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
    J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
    Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
    Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine blood tests as a potential diagnostic tool for COVID-19.
    Ferrari D; Motta A; Strollo M; Banfi G; Locatelli M
    Clin Chem Lab Med; 2020 Jun; 58(7):1095-1099. PubMed ID: 32301746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of severe cases with COVID-19: a meta-analysis.
    Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
    Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19.
    Sharma P; Kumar A
    Diabetes Metab Syndr; 2020; 14(5):825-827. PubMed ID: 32540736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.